AI-powered data and market intelligence solutions - We leverage AI to transform clinical trial data and market intelligence into actionable insights to accelerate pharma innovation, competitive strategy, and patient outcomes. Our solutions include KOL monitoring, real-time high-impact news, intuitive cancer biomarker database and comprehensive conference planners. To keep you at the forefront of clinical and industry developments, LARVOL curates pharmaceutical and biotech competitive intelligence using a proven combination of broad therapeutic-area expertise and technological innovation. Our team of MDs and PhDs collates data from over 25,000 sources and distills the most relevant findings into concise reports that provide real-time insights and time-saving analysis. Our global team is comprised of professionals with expertise in all major therapeutic areas, with a special focus on oncology, inflammation, cardiovascular, and CNS. We are a valued partner to numerous Fortune 500 companies as well as small and mid-size pharma and biotech enterprises.
Looking for a particular LARVOL employee's phone or email?
LARVOL Questions
The LARVOL annual revenue was $35.7 million in 2026.
Bruno is the Founder and CEO of LARVOL.
105 people are employed at LARVOL.
LARVOL is based in San Francisco, California.
The NAICS codes for LARVOL are [54, 51, 518210, 541, 518, 51821, 5182].
The SIC codes for LARVOL are [73, 737].
Top LARVOL Employees
-
Bruno
Founder and CEO at LARVOL
San Francisco, CA, US25+ -
Mark Gramling
Vice President, Oncology at LARVOL
Nashville, TN, US21 -
22
-
Michael Bolster
Head of Sales and Strategy at LARVOL
Pinetta, FL, US34 -
Nikki Makkar
Vice President, People Operations at LARVOL
Edmonton, AB, CA21 -
1
-
Sandeep Ghosal
Director - KOL and Life Sciences Strategy at LARVOL
Bengaluru, KA, IN21 -
Aviva Fridman
Senior Consultant at LARVOL
United States32 -
Kalpana Devi
Director at LARVOL
Mumbai, MH, IN2
Related Companies
